Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108997229A reveals mild synthesis for high-purity intermediates. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturing partners.
Novel zinc-mediated reduction route for Roxadustat intermediates. High purity, scalable, and cost-effective manufacturing solution for pharmaceutical supply chains.
Patent CN103159641A reveals low-cost lithiation route for tolvaptan intermediate ensuring high purity and supply chain stability for global pharmaceutical manufacturing.
Patent CN106978368B details a novel nitrilase biocatalysis route for L-glufosinate precursors, offering high optical purity and reduced environmental impact for agrochemical manufacturing.
Enzymatic resolution patent CN112442523B enables high-purity chiral intermediate production with reduced costs and scalable supply chain reliability for global pharma.
Novel organocatalytic route offers 99.8% ee. Green scalable process for pharma intermediates. Cost-effective supply chain solution for global buyers.
Patent CN111154746B reveals high-activity amidase mutants enabling green, scalable production of 2-chloronicotinic acid for agrochemical and pharmaceutical applications.
Patent CN105461621A reveals green hydrogenation for pyridine-2-formic acid. Reduces waste, lowers cost, ensures supply chain reliability for global agrochemical manufacturers.
Patent CN104447543B reveals a high-yield synthesis route for 3-amino-7,8-difluoroquinoline intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover a cost-effective synthesis for 3-(2,3-dihydrobenzofuran-5-yl)propionic acid via patent CN101648931A. Optimize your Ramelteon supply chain with scalable, high-purity methods.
Patent CN103172528B details a high-efficiency tranexamic acid method. It offers significant supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN108866028B details a mutant amino lyase for producing (R)-3-aminobutyric acid. This biocatalytic route offers superior stereoselectivity and cost efficiency for Dolutegravir intermediates.
Patent CN115851685A reveals a breakthrough nitrilase mutant for efficient 3-hydroxy-3-methylbutyric acid production, offering significant cost reduction and green manufacturing advantages.
Novel synthesis route for PARP inhibitor intermediates offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN104561142A reveals nitrilase biosynthesis for statin intermediates. Offers mild conditions, high yield, and supply chain stability for global pharmaceutical manufacturing.
Patent CN120865012A reveals high-purity synthesis for diatrizoic acid impurity D, ensuring supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN107686457A details ferrous salt catalysis for high-purity pharmaceutical intermediates. Discover cost reduction and supply chain advantages.
Patent CN115611961A reveals a mild elimination route for Cholic Acid Intermediate A2, enabling virus-free API production with scalable supply chain advantages.
Patent CN115611961A details a novel chemical synthesis for Cholic Acid Intermediate A2, offering a virus-free alternative to animal extraction with scalable manufacturing capabilities.
Novel LiOH and DMSO hydrolysis method ensures high purity Bempedoic acid intermediate with reduced safety risks and scalable production capabilities for global supply chains.